Inorganic Chemistry
Article
3
3
3
3
3,18-m), 7.65 (d, J = 7.8 Hz, 4H, 8,13-m), 7.60 (t, J = 7.3 Hz, 2H,
3,18-p), 2.68 (s, 6H, CH3), −3.29 (bs, 2H, H19, H21). 13C NMR
(150.90 MHz, CDCl3, 300 K): δ 140.4 (3,18-ipso), 137.7 (8,13-p),
137.5 (8,13-ipso), 136.2 (9,12), 134.3 (8,13-o), 133.9 (7,14), 132.7
(3,18-o), 132.3 (4,17), 129.5 (10,11), 129.2 (3,8,13,18-m), 126.9
(3,18-p), 122.6 (6,15), 117.9 (1,2), 117.5 (5,16), 116.8 (8,13), 102.3
(3,18), 21.5 (Me).
(bs, 2H, 8,13-o), 8.41 (d, J = 4.5 Hz, H6, H15), 7.81 (t, J = 7.6 Hz,
3
4H, 3,18-m), 7.69 (bs, 2H, 8,13-o), 7.60 (t, J = 7.6 Hz, 2H, 3,18-p),
7.56 (bs, 2H, 8,13-m), 7.53 (bs, 2H, 8,13-m), 2.65 (s, 6H, Me). H
1
NMR (600 MHz, CDCl3, 282 K): δ 9.04 (s, 2H, H10, H11), 8.74 (d,
3J = 4.6 Hz, 2H, H5, H16), 8.64 (d, 3J = 7.8 Hz, 4H, 3,18-o), 8.62 (d,
3J = 7.7 Hz, 2H, 8,13-o), 8.44 (d, J = 4.6 Hz, H6, H15), 7.79 (t, J =
3
3
3
7.8 Hz, 4H, 3,18-m), 7.67 (d, J = 7.5 Hz, 2H, 8,13-m′), 7.60 (d, 2H,
3
3
Dehydro-3,18-diphenyl-8,13-di-p-tolyl-20-thiaethynepor-
phyrin Dication ([13-H22+]). The solution of 7 in CDCl3 or CD2Cl2
was placed in an NMR tube (typically, a sample of ∼1−2 mg of 16).
Then excess of DDQ in the presence of HBF4 etherate was added, and
a change of color from orange to brown-red was observed. The
oxidation of 7 afforded a 1H NMR spectrum readily assigned to [13-H2]2+.
HR-MS (ESI, m/z): 619.2206 (619.2208 calcd for [C44H30N2S +
8,13-o′), 7.58 (t, J = 7.4 Hz, 2H, 3,18-p), 7.51 (d, J = 7.5 Hz, 2H,
8,13-m), 2.64 (s, 6H, Me). 13C NMR (150.90 MHz, CDCl3, 300 K): δ
159.5 (α-pyr), 143.1 (α-pyr), 140.0 (8,13-p), 139.7 (8,13-ipso), 139.4
(3,18-ipso), 136.6 (8,13-o), 133.4 (3,18-o), 131.0 (3,18-m), 130.9
(10,11), 130.7 (8,13-m), 129.0 (3,18-p), 128.0 (9,12), 125.7 (8,13),
124.5 (5,16), 124.2 (6,15), 115.8 (1,2), 107.2 (3,18), 22.8 (Me).
Palladium(II) Complex of 3,18-Diphenyl-8,13-di-p-tolyl-20-
thiaetheneporphyrin (14-Pd). The solution of 7-Pd in CD2Cl2 was
placed in an NMR tube (typically, a sample of ∼1−2 mg of 7-Pd).
Then the ethanol solution of NaBH4 was added gradually (at 30 min
intervals) through a 25 μL microsyringe. The addition of a reducting
agent was stopped when the entire amount of 7-Pd was converted to
14-Pd. HR-MS (ESI, m/z): 725.1265 (725.1248 calcd for
H]+). H NMR (600 MHz, CDCl3, 300 K): δ 25.35 (s, 2H, H19,
1
H21), 7.25 (t, 3J = 7.5 Hz, 2H, 3,18-p), 7.10 (t, 3J = 7.9 Hz, 4H, 3,18-
m), 7.06 (d, 3J = 8.1 Hz, 4H, 8,13-m), 6.96 (s, 2H, H10, H11), 6.80 (d,
3J = 8.3 Hz, 4H, 8,13-o), 6.60 (d, J = 7.9 Hz, 4H, 3,18-o), 6.08 (dd,
3
3J = 5.0 Hz, 4J = 1.9 Hz, 2H, H5, H16), 5.96 (dd, 3J = 5.0 Hz, 4J = 1.9
Hz, 2H, H6, H15), 2.34 (s, 6H, Me).
[C44H31N2S106Pd]−). H NMR (600 MHz, CD2Cl2, 180 K): δ 8.76
1
iso-Thiaethyneporphyrin (12′-H+). The solution of 7 in CD2Cl2
was placed in an NMR tube (typically, a sample of ∼1−2 mg of 7).
The titration of 7 was carried out with HBF4 etherate or TFA at 298 K.
3
3
(s, 1H, H2), 8.62 (d, 1H, J = 7.8 Hz, 8-o), 8.56 (d, J = 7.8 Hz, 1H,
13-o), 8.24 (d, 3J = 7.3 Hz, 1H, 18-o′), 8.17 (d, 3J = 5.3 Hz, 1H, H11),
8.15 (d, 3J = 7.3 Hz, 1H, 18-o), 8.06 (d, 3J = 7.5 Hz, 1H, 3-o′), 8.05 (d,
3J = 5.3 Hz, 1H, H10), 7.89 (d, 3J = 3.8 Hz, 1H, H5), 7.85 (d, 3J = 7.3
Hz, 3-o), 7.84 (d, 3J = 3.8 Hz, 1H, H6), 7.81 (d, 3J = 3.8 Hz, 1H, H15),
1
The progress of the reaction was followed by NMR spectroscopy. H
NMR (600 MHz, CD2Cl2, 300 K): δ 9.65, 9.50, 8.06, 7.81, 7.70, 7.59−
7.55, 7.54, 7.52, 7.46, 7.44, 7.32, 7.27, 7.24, 7.23, 7.12, 6.35, 5.50, 2.52,
2.39.
3
3
7.77 (d, J = 3.6 Hz, 1H, H16), 7.66 (t, J = 7.3 Hz, 1H, 18-m′), 7.59
3
3
(t, J = 7.3 Hz, 1H, 18-m), 7.57 (t, J = 7.1 Hz, 1H, 3-m′), 7.55
(d, 1H + 1H, 8,13-m), 7.44 (t, 3J = 7.4 Hz, 1H, 3-m), 7.40 (t, 3J = 7.4
Hz, 1H, 18-p), 7.39 (t, 1H, 3-p), 7.37 (d, 3J = 7.8 Hz, 1H, 13-o′), 7.33
(d, 3J = 7.8 Hz, 1H, 13-m′), 7.21 (d, 3J = 7.8 Hz, 1H, 8-m′), 7.03 (d, 3
J = 7.8 Hz, 1H, 8-o′), 2.49 (s, 3H, 13-Me), 2.47 (s, 3H, 8-Me). 13C
NMR (150.90 MHz, CDCl3, 300 K): δ 153.1, 150.8, 148.1, 140.7,
140.0, 139.7, 139.6, 137.4, 137.2, 137.1, 136.3, 135.8−135.7, 135.2,
134.3, 133.9, 133.7, 133.5, 132.7, 132.5, 132.1, 130.8, 130.6, 129.5,
129.3−129.2, 129.1, 129.0, 128.8, 128.4, 128.1, 127.7, 127.6, 127.1,
126.1−125.9, 122.1, 122.0 (C2), 119.2, 118.1, 115.9, 22.0.
Nickel(II) Complex of 3,18-Diphenyl-8,13-di-p-tolyl-20-
thiaethyneporphyrin (7-Ni). Nickel(II) acetate (28 mg, 0.1
mmol) in 5 mL of DMF was added to a dark-orange toluene solution
of 7 (7 mg, 0.01 mmol). The mixture was refluxed under nitrogen. The
progress of the reaction was followed by UV−vis spectroscopy. After
the disappearance of absorption peaks ascribed to the starting material
(it usually takes ∼5 h), the solvent was evaporated to dryness and the
residue was purified by chromatography on silica gel. The main brown-
red fraction eluted with dichloromethane was collected and recrystal-
lized from dichloromethane/n-hexane to give 7-Ni with 50% yield.
UV−vis [λmax, nm (log ε, M−1 cm−1)]: 291.0 (4.4), 435.0 (4.6), 595.0
(3.7). HR-MS (ESI, m/z): 676.1483 (676.1483 calcd for
Instrumentation. NMR spectra were measured on Bruker Avance
1
500 MHz and Bruker Avance 600 MHz spectrometers. H and 13C
1
[C44H30N2SNi]•+). H NMR (500 MHz, CD2Cl2, 300 K): δ 8.97 (s,
NMR shifts were referenced to the residual resonances of deuterated
solvents. Two-dimensional NMR spectra were recorded typically with
2048 data points in the t2 domain and up to 1024 points in the t1
domain, with a 1 s recovery delay. Absorption spectra were recorded
on a Varian Carry-50 Bio spectrophotometer. Mass spectra (high
3
3
2H, H10, H11), 8.44 (d, J = 4.5 Hz, 2H, H5, H16), 8.43 (d, J = 7.6
3
Hz, 4H, 3,18-o), 8.22 (d, J = 4.5 Hz, 2H, H6, H15), 7.94 (bs, 4H,
3
3
8,13-o), 7.72 (t, J = 7.6 Hz, 4H, 3,18-m), 7.55 (t, J = 7.6 Hz, 2H,
3,18-p), 7.54 (d, 3J = 8.0 Hz, 4H, 8,13-m), 2.59 (s, 6H, Me). 13C NMR
(150.90 MHz, CD2Cl2, 300 K): δ 160.9 (α-pyr), 145.9 (α-pyr), 140.0
(8,13-p), 139.5 (8,13-ipso), 138.7 (3,18-ipso), 133.9 (8,13-o), 132.6
(3,18-o), 130.8 (3,18-m), 130.7 (8,13-m), 129.7 (10,11), 128.9 (3,18-
p), 127.1 (9,12), 127.0 (6,15), 124.2 (8,13), 124.0 (5,16), 116.8 (1,2),
105.9 (3,18), 22.8 (Me).
resolution and accurate mass) were recorded on a Bruker micro-TOF-
̈
Q spectrometer using the electrospray technique. X-ray-quality crystals
of 7 and 7-Pd were prepared by the diffusion of methanol or n-hexane
and o-dichlorobenzene, respectively, into a chloroform solution
contained in a tube stored in a refrigerator. X-ray-quality crystals of
7-Ni and 11 were prepared by the diffusion of n-hexane or n-heptane,
respectively, into a dichloromethane solution contained in a tube
stored at room temperature. Data were collected at 100 K for 7 and
7-Pd, 7-Ni and at 110 K for 11 on an Xcalibur PX-k geometry
diffractometer, with Mo Kα radiation (λ = 0.71073 Å). Data were
corrected for Lorentz and polarization effects. An analytical absorption
correction was applied for 7-Pd and 7-Ni. Crystal data are compiled in
Table S1 in the Supporting Information. Structures were solved by a
heavy metal (7-Pd) and direct (7, 7-Ni, and 11) methods with
SHELXS-97 and refined by a full-matrix least-squares method by
using SHELXL-97 with anisotropic thermal parameters for almost all
non-hydrogen atoms. Scattering factors were those incorporated into
SHELXS-97.116,117 Electrochemical measurements were performed
with an EA9C multifunctional electrochemical analyzer under the
following conditions: CH2Cl2; 0.1 M TBAP; scan rate, 50 mV s−1;
working electrode, glassy carbon disk; auxliary electrode, platinum
wire; reference electrode, Ag/AgCl. The voltammograms were
referenced against the half-wave potential of Fc/Fc+.
Dipyridinenickel(II) Complex of 3,18-Diphenyl-8,13-di-
p-tolyl-20-thiaethyneporphyrin (7-Ni-py). The solution of 7-Ni
in CD2Cl2 was placed in an NMR tube (typically, a sample of ∼1−2
mg of 7-Ni). Titration of 7-Ni with pyridine at 200 K afforded the 1H
NMR spectrum readily assigned to 7-Ni-py. 1H NMR (600 MHz,
CD2Cl2, 200 K): δ 117.0 (pyrr), 71.2 (H3), 54.9 (pyrr), 22.3 (H4),
−17.4 (th).
Palladium(II) Complex of 3,18-Diphenyl-8,13-di-p-tolyl-20-
thiaethyneporphyrin (7-Pd). Palladium(II) acetate (36 mg, 0.16
mmol) was added to a dark-orange toluene solution of 7 (10 mg, 0.016
mmol). The mixture was refluxed. The progress of the reaction was
followed by UV−vis spectroscopy. After the disappearance of
absorption peaks ascribed to the starting material (it usually takes
∼4 h), the solvent was evaporated to dryness and the residue was
purified by chromatography on silica gel. The main brown-red fraction
eluted with dichloromethane was collected and recrystallized from
CH2Cl2/CH3OH to give 7-Pd with 60% yield. UV−vis [λmax, nm (log
ε, M−1 cm−1)]: 285.5 (4.4), 373.0 (4.1), 462.0 (4.9), 578.5 (3.8). HR-
MS (ESI, m/z): 724.1175 (724.1180 calcd for [C44H30N2S106Pd]•+).
1H NMR (600 MHz, CD2Cl2, 300 K): δ 9.04 (s, 2H, H10, H11), 8.72
DFT Calculations. Geometry optimizations were carried out within
unconstrained C1 symmetry, with the starting coordinates derived from
molecular mechanic calculations.118 Becke’s three-parameter exchange
(d, 3J = 4.5 Hz, 2H, H5, H16), 8.64 (d, 3J = 7.6 Hz, 4H, 3,18-o), 8.61
3257
dx.doi.org/10.1021/ic2027175 | Inorg. Chem. 2012, 51, 3247−3260